Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Cystic Fibrosis Drugs Market Growth 2022-2028

  • LP 4873053
  • 122 Pages
  • February 2022
  • Pharmaceuticals
Download Sample    Get Discount   
 
As the global economy mends, the 2021 growth of Cystic Fibrosis Drugs will have significant change from previous year. According to our (LP Information) latest study, the global Cystic Fibrosis Drugs market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Cystic Fibrosis Drugs market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.

The United States Cystic Fibrosis Drugs market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Cystic Fibrosis Drugs market, reaching US$ million by the year 2028. As for the Europe Cystic Fibrosis Drugs landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Cystic Fibrosis Drugs players cover Actavis, F. Hoffmann-La Roche, Gilead Sciences, and Novartis, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Cystic Fibrosis Drugs market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6

Oral Cystic Fibrosis Drugs

Injection Cystic Fibrosis Drugs

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.

Hospitals

Clinics

Other

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include

Actavis

F. Hoffmann-La Roche

Gilead Sciences

Novartis

Vertex Pharmaceuticals

Abbott

Anthera Pharmaceuticals

Arcturus Therapeutics

Boehringer Ingelheim

Chiesi Farmaceutici

Corbus Pharmaceuticals

Genzyme

Insmed

Johnson & Johnson

Merck Sharp & Dohme

Neovii Biotech

Novo Nordisk

PharmaSwiss

Pharmaxis

Proteostasis Therapeutics

PTC Therapeutics

United Medical

Venus Remedies

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Cystic Fibrosis Drugs Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Cystic Fibrosis Drugs by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Cystic Fibrosis Drugs by Country/Region, 2017, 2022 & 2028

2.2 Cystic Fibrosis Drugs Segment by Type

2.2.1 Oral Cystic Fibrosis Drugs

2.2.2 Injection Cystic Fibrosis Drugs

2.3 Cystic Fibrosis Drugs Sales by Type

2.3.1 Global Cystic Fibrosis Drugs Sales Market Share by Type (2017-2022)

2.3.2 Global Cystic Fibrosis Drugs Revenue and Market Share by Type (2017-2022)

2.3.3 Global Cystic Fibrosis Drugs Sale Price by Type (2017-2022)

2.4 Cystic Fibrosis Drugs Segment by Application

2.4.1 Hospitals

2.4.2 Clinics

2.4.3 Other

2.5 Cystic Fibrosis Drugs Sales by Application

2.5.1 Global Cystic Fibrosis Drugs Sale Market Share by Application (2017-2022)

2.5.2 Global Cystic Fibrosis Drugs Revenue and Market Share by Application (2017-2022)

2.5.3 Global Cystic Fibrosis Drugs Sale Price by Application (2017-2022)

3 Global Cystic Fibrosis Drugs by Company

3.1 Global Cystic Fibrosis Drugs Breakdown Data by Company

3.1.1 Global Cystic Fibrosis Drugs Annual Sales by Company (2020-2022)

3.1.2 Global Cystic Fibrosis Drugs Sales Market Share by Company (2020-2022)

3.2 Global Cystic Fibrosis Drugs Annual Revenue by Company (2020-2022)

3.2.1 Global Cystic Fibrosis Drugs Revenue by Company (2020-2022)

3.2.2 Global Cystic Fibrosis Drugs Revenue Market Share by Company (2020-2022)

3.3 Global Cystic Fibrosis Drugs Sale Price by Company

3.4 Key Manufacturers Cystic Fibrosis Drugs Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Cystic Fibrosis Drugs Product Location Distribution

3.4.2 Players Cystic Fibrosis Drugs Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Cystic Fibrosis Drugs by Geographic Region

4.1 World Historic Cystic Fibrosis Drugs Market Size by Geographic Region (2017-2022)

4.1.1 Global Cystic Fibrosis Drugs Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Cystic Fibrosis Drugs Annual Revenue by Geographic Region

4.2 World Historic Cystic Fibrosis Drugs Market Size by Country/Region (2017-2022)

4.2.1 Global Cystic Fibrosis Drugs Annual Sales by Country/Region (2017-2022)

4.2.2 Global Cystic Fibrosis Drugs Annual Revenue by Country/Region

4.3 Americas Cystic Fibrosis Drugs Sales Growth

4.4 APAC Cystic Fibrosis Drugs Sales Growth

4.5 Europe Cystic Fibrosis Drugs Sales Growth

4.6 Middle East & Africa Cystic Fibrosis Drugs Sales Growth

5 Americas

5.1 Americas Cystic Fibrosis Drugs Sales by Country

5.1.1 Americas Cystic Fibrosis Drugs Sales by Country (2017-2022)

5.1.2 Americas Cystic Fibrosis Drugs Revenue by Country (2017-2022)

5.2 Americas Cystic Fibrosis Drugs Sales by Type

5.3 Americas Cystic Fibrosis Drugs Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Cystic Fibrosis Drugs Sales by Region

6.1.1 APAC Cystic Fibrosis Drugs Sales by Region (2017-2022)

6.1.2 APAC Cystic Fibrosis Drugs Revenue by Region (2017-2022)

6.2 APAC Cystic Fibrosis Drugs Sales by Type

6.3 APAC Cystic Fibrosis Drugs Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Cystic Fibrosis Drugs by Country

7.1.1 Europe Cystic Fibrosis Drugs Sales by Country (2017-2022)

7.1.2 Europe Cystic Fibrosis Drugs Revenue by Country (2017-2022)

7.2 Europe Cystic Fibrosis Drugs Sales by Type

7.3 Europe Cystic Fibrosis Drugs Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Cystic Fibrosis Drugs by Country

8.1.1 Middle East & Africa Cystic Fibrosis Drugs Sales by Country (2017-2022)

8.1.2 Middle East & Africa Cystic Fibrosis Drugs Revenue by Country (2017-2022)

8.2 Middle East & Africa Cystic Fibrosis Drugs Sales by Type

8.3 Middle East & Africa Cystic Fibrosis Drugs Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Cystic Fibrosis Drugs

10.3 Manufacturing Process Analysis of Cystic Fibrosis Drugs

10.4 Industry Chain Structure of Cystic Fibrosis Drugs

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Cystic Fibrosis Drugs Distributors

11.3 Cystic Fibrosis Drugs Customer

12 World Forecast Review for Cystic Fibrosis Drugs by Geographic Region

12.1 Global Cystic Fibrosis Drugs Market Size Forecast by Region

12.1.1 Global Cystic Fibrosis Drugs Forecast by Region (2023-2028)

12.1.2 Global Cystic Fibrosis Drugs Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Cystic Fibrosis Drugs Forecast by Type

12.7 Global Cystic Fibrosis Drugs Forecast by Application

13 Key Players Analysis

13.1 Actavis

13.1.1 Actavis Company Information

13.1.2 Actavis Cystic Fibrosis Drugs Product Offered

13.1.3 Actavis Cystic Fibrosis Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Actavis Main Business Overview

13.1.5 Actavis Latest Developments

13.2 F. Hoffmann-La Roche

13.2.1 F. Hoffmann-La Roche Company Information

13.2.2 F. Hoffmann-La Roche Cystic Fibrosis Drugs Product Offered

13.2.3 F. Hoffmann-La Roche Cystic Fibrosis Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 F. Hoffmann-La Roche Main Business Overview

13.2.5 F. Hoffmann-La Roche Latest Developments

13.3 Gilead Sciences

13.3.1 Gilead Sciences Company Information

13.3.2 Gilead Sciences Cystic Fibrosis Drugs Product Offered

13.3.3 Gilead Sciences Cystic Fibrosis Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Gilead Sciences Main Business Overview

13.3.5 Gilead Sciences Latest Developments

13.4 Novartis

13.4.1 Novartis Company Information

13.4.2 Novartis Cystic Fibrosis Drugs Product Offered

13.4.3 Novartis Cystic Fibrosis Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Novartis Main Business Overview

13.4.5 Novartis Latest Developments

13.5 Vertex Pharmaceuticals

13.5.1 Vertex Pharmaceuticals Company Information

13.5.2 Vertex Pharmaceuticals Cystic Fibrosis Drugs Product Offered

13.5.3 Vertex Pharmaceuticals Cystic Fibrosis Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Vertex Pharmaceuticals Main Business Overview

13.5.5 Vertex Pharmaceuticals Latest Developments

13.6 Abbott

13.6.1 Abbott Company Information

13.6.2 Abbott Cystic Fibrosis Drugs Product Offered

13.6.3 Abbott Cystic Fibrosis Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Abbott Main Business Overview

13.6.5 Abbott Latest Developments

13.7 Anthera Pharmaceuticals

13.7.1 Anthera Pharmaceuticals Company Information

13.7.2 Anthera Pharmaceuticals Cystic Fibrosis Drugs Product Offered

13.7.3 Anthera Pharmaceuticals Cystic Fibrosis Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Anthera Pharmaceuticals Main Business Overview

13.7.5 Anthera Pharmaceuticals Latest Developments

13.8 Arcturus Therapeutics

13.8.1 Arcturus Therapeutics Company Information

13.8.2 Arcturus Therapeutics Cystic Fibrosis Drugs Product Offered

13.8.3 Arcturus Therapeutics Cystic Fibrosis Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Arcturus Therapeutics Main Business Overview

13.8.5 Arcturus Therapeutics Latest Developments

13.9 Boehringer Ingelheim

13.9.1 Boehringer Ingelheim Company Information

13.9.2 Boehringer Ingelheim Cystic Fibrosis Drugs Product Offered

13.9.3 Boehringer Ingelheim Cystic Fibrosis Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Boehringer Ingelheim Main Business Overview

13.9.5 Boehringer Ingelheim Latest Developments

13.10 Chiesi Farmaceutici

13.10.1 Chiesi Farmaceutici Company Information

13.10.2 Chiesi Farmaceutici Cystic Fibrosis Drugs Product Offered

13.10.3 Chiesi Farmaceutici Cystic Fibrosis Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Chiesi Farmaceutici Main Business Overview

13.10.5 Chiesi Farmaceutici Latest Developments

13.11 Corbus Pharmaceuticals

13.11.1 Corbus Pharmaceuticals Company Information

13.11.2 Corbus Pharmaceuticals Cystic Fibrosis Drugs Product Offered

13.11.3 Corbus Pharmaceuticals Cystic Fibrosis Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 Corbus Pharmaceuticals Main Business Overview

13.11.5 Corbus Pharmaceuticals Latest Developments

13.12 Genzyme

13.12.1 Genzyme Company Information

13.12.2 Genzyme Cystic Fibrosis Drugs Product Offered

13.12.3 Genzyme Cystic Fibrosis Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.12.4 Genzyme Main Business Overview

13.12.5 Genzyme Latest Developments

13.13 Insmed

13.13.1 Insmed Company Information

13.13.2 Insmed Cystic Fibrosis Drugs Product Offered

13.13.3 Insmed Cystic Fibrosis Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.13.4 Insmed Main Business Overview

13.13.5 Insmed Latest Developments

13.14 Johnson & Johnson

13.14.1 Johnson & Johnson Company Information

13.14.2 Johnson & Johnson Cystic Fibrosis Drugs Product Offered

13.14.3 Johnson & Johnson Cystic Fibrosis Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.14.4 Johnson & Johnson Main Business Overview

13.14.5 Johnson & Johnson Latest Developments

13.15 Merck Sharp & Dohme

13.15.1 Merck Sharp & Dohme Company Information

13.15.2 Merck Sharp & Dohme Cystic Fibrosis Drugs Product Offered

13.15.3 Merck Sharp & Dohme Cystic Fibrosis Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.15.4 Merck Sharp & Dohme Main Business Overview

13.15.5 Merck Sharp & Dohme Latest Developments

13.16 Neovii Biotech

13.16.1 Neovii Biotech Company Information

13.16.2 Neovii Biotech Cystic Fibrosis Drugs Product Offered

13.16.3 Neovii Biotech Cystic Fibrosis Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.16.4 Neovii Biotech Main Business Overview

13.16.5 Neovii Biotech Latest Developments

13.17 Novo Nordisk

13.17.1 Novo Nordisk Company Information

13.17.2 Novo Nordisk Cystic Fibrosis Drugs Product Offered

13.17.3 Novo Nordisk Cystic Fibrosis Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.17.4 Novo Nordisk Main Business Overview

13.17.5 Novo Nordisk Latest Developments

13.18 PharmaSwiss

13.18.1 PharmaSwiss Company Information

13.18.2 PharmaSwiss Cystic Fibrosis Drugs Product Offered

13.18.3 PharmaSwiss Cystic Fibrosis Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.18.4 PharmaSwiss Main Business Overview

13.18.5 PharmaSwiss Latest Developments

13.19 Pharmaxis

13.19.1 Pharmaxis Company Information

13.19.2 Pharmaxis Cystic Fibrosis Drugs Product Offered

13.19.3 Pharmaxis Cystic Fibrosis Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.19.4 Pharmaxis Main Business Overview

13.19.5 Pharmaxis Latest Developments

13.20 Proteostasis Therapeutics

13.20.1 Proteostasis Therapeutics Company Information

13.20.2 Proteostasis Therapeutics Cystic Fibrosis Drugs Product Offered

13.20.3 Proteostasis Therapeutics Cystic Fibrosis Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.20.4 Proteostasis Therapeutics Main Business Overview

13.20.5 Proteostasis Therapeutics Latest Developments

13.21 PTC Therapeutics

13.21.1 PTC Therapeutics Company Information

13.21.2 PTC Therapeutics Cystic Fibrosis Drugs Product Offered

13.21.3 PTC Therapeutics Cystic Fibrosis Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.21.4 PTC Therapeutics Main Business Overview

13.21.5 PTC Therapeutics Latest Developments

13.22 United Medical

13.22.1 United Medical Company Information

13.22.2 United Medical Cystic Fibrosis Drugs Product Offered

13.22.3 United Medical Cystic Fibrosis Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.22.4 United Medical Main Business Overview

13.22.5 United Medical Latest Developments

13.23 Venus Remedies

13.23.1 Venus Remedies Company Information

13.23.2 Venus Remedies Cystic Fibrosis Drugs Product Offered

13.23.3 Venus Remedies Cystic Fibrosis Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.23.4 Venus Remedies Main Business Overview

13.23.5 Venus Remedies Latest Developments

14 Research Findings and Conclusion

List of Tables

Table 1. Cystic Fibrosis Drugs Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Cystic Fibrosis Drugs Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Oral Cystic Fibrosis Drugs

Table 4. Major Players of Injection Cystic Fibrosis Drugs

Table 5. Global Cystic Fibrosis Drugs Sales by Type (2017-2022) & (K Pcs)

Table 6. Global Cystic Fibrosis Drugs Sales Market Share by Type (2017-2022)

Table 7. Global Cystic Fibrosis Drugs Revenue by Type (2017-2022) & ($ million)

Table 8. Global Cystic Fibrosis Drugs Revenue Market Share by Type (2017-2022)

Table 9. Global Cystic Fibrosis Drugs Sale Price by Type (2017-2022) & (USD/Pcs)

Table 10. Global Cystic Fibrosis Drugs Sales by Application (2017-2022) & (K Pcs)

Table 11. Global Cystic Fibrosis Drugs Sales Market Share by Application (2017-2022)

Table 12. Global Cystic Fibrosis Drugs Revenue by Application (2017-2022)

Table 13. Global Cystic Fibrosis Drugs Revenue Market Share by Application (2017-2022)

Table 14. Global Cystic Fibrosis Drugs Sale Price by Application (2017-2022) & (USD/Pcs)

Table 15. Global Cystic Fibrosis Drugs Sales by Company (2020-2022) & (K Pcs)

Table 16. Global Cystic Fibrosis Drugs Sales Market Share by Company (2020-2022)

Table 17. Global Cystic Fibrosis Drugs Revenue by Company (2020-2022) ($ Millions)

Table 18. Global Cystic Fibrosis Drugs Revenue Market Share by Company (2020-2022)

Table 19. Global Cystic Fibrosis Drugs Sale Price by Company (2020-2022) & (USD/Pcs)

Table 20. Key Manufacturers Cystic Fibrosis Drugs Producing Area Distribution and Sales Area

Table 21. Players Cystic Fibrosis Drugs Products Offered

Table 22. Cystic Fibrosis Drugs Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 23. New Products and Potential Entrants

Table 24. Mergers & Acquisitions, Expansion

Table 25. Global Cystic Fibrosis Drugs Sales by Geographic Region (2017-2022) & (K Pcs)

Table 26. Global Cystic Fibrosis Drugs Sales Market Share Geographic Region (2017-2022)

Table 27. Global Cystic Fibrosis Drugs Revenue by Geographic Region (2017-2022) & ($ millions)

Table 28. Global Cystic Fibrosis Drugs Revenue Market Share by Geographic Region (2017-2022)

Table 29. Global Cystic Fibrosis Drugs Sales by Country/Region (2017-2022) & (K Pcs)

Table 30. Global Cystic Fibrosis Drugs Sales Market Share by Country/Region (2017-2022)

Table 31. Global Cystic Fibrosis Drugs Revenue by Country/Region (2017-2022) & ($ millions)

Table 32. Global Cystic Fibrosis Drugs Revenue Market Share by Country/Region (2017-2022)

Table 33. Americas Cystic Fibrosis Drugs Sales by Country (2017-2022) & (K Pcs)

Table 34. Americas Cystic Fibrosis Drugs Sales Market Share by Country (2017-2022)

Table 35. Americas Cystic Fibrosis Drugs Revenue by Country (2017-2022) & ($ Millions)

Table 36. Americas Cystic Fibrosis Drugs Revenue Market Share by Country (2017-2022)

Table 37. Americas Cystic Fibrosis Drugs Sales by Type (2017-2022) & (K Pcs)

Table 38. Americas Cystic Fibrosis Drugs Sales Market Share by Type (2017-2022)

Table 39. Americas Cystic Fibrosis Drugs Sales by Application (2017-2022) & (K Pcs)

Table 40. Americas Cystic Fibrosis Drugs Sales Market Share by Application (2017-2022)

Table 41. APAC Cystic Fibrosis Drugs Sales by Region (2017-2022) & (K Pcs)

Table 42. APAC Cystic Fibrosis Drugs Sales Market Share by Region (2017-2022)

Table 43. APAC Cystic Fibrosis Drugs Revenue by Region (2017-2022) & ($ Millions)

Table 44. APAC Cystic Fibrosis Drugs Revenue Market Share by Region (2017-2022)

Table 45. APAC Cystic Fibrosis Drugs Sales by Type (2017-2022) & (K Pcs)

Table 46. APAC Cystic Fibrosis Drugs Sales Market Share by Type (2017-2022)

Table 47. APAC Cystic Fibrosis Drugs Sales by Application (2017-2022) & (K Pcs)

Table 48. APAC Cystic Fibrosis Drugs Sales Market Share by Application (2017-2022)

Table 49. Europe Cystic Fibrosis Drugs Sales by Country (2017-2022) & (K Pcs)

Table 50. Europe Cystic Fibrosis Drugs Sales Market Share by Country (2017-2022)

Table 51. Europe Cystic Fibrosis Drugs Revenue by Country (2017-2022) & ($ Millions)

Table 52. Europe Cystic Fibrosis Drugs Revenue Market Share by Country (2017-2022)

Table 53. Europe Cystic Fibrosis Drugs Sales by Type (2017-2022) & (K Pcs)

Table 54. Europe Cystic Fibrosis Drugs Sales Market Share by Type (2017-2022)

Table 55. Europe Cystic Fibrosis Drugs Sales by Application (2017-2022) & (K Pcs)

Table 56. Europe Cystic Fibrosis Drugs Sales Market Share by Application (2017-2022)

Table 57. Middle East & Africa Cystic Fibrosis Drugs Sales by Country (2017-2022) & (K Pcs)

Table 58. Middle East & Africa Cystic Fibrosis Drugs Sales Market Share by Country (2017-2022)

Table 59. Middle East & Africa Cystic Fibrosis Drugs Revenue by Country (2017-2022) & ($ Millions)

Table 60. Middle East & Africa Cystic Fibrosis Drugs Revenue Market Share by Country (2017-2022)

Table 61. Middle East & Africa Cystic Fibrosis Drugs Sales by Type (2017-2022) & (K Pcs)

Table 62. Middle East & Africa Cystic Fibrosis Drugs Sales Market Share by Type (2017-2022)

Table 63. Middle East & Africa Cystic Fibrosis Drugs Sales by Application (2017-2022) & (K Pcs)

Table 64. Middle East & Africa Cystic Fibrosis Drugs Sales Market Share by Application (2017-2022)

Table 65. Key Market Drivers & Growth Opportunities of Cystic Fibrosis Drugs

Table 66. Key Market Challenges & Risks of Cystic Fibrosis Drugs

Table 67. Key Industry Trends of Cystic Fibrosis Drugs

Table 68. Cystic Fibrosis Drugs Raw Material

Table 69. Key Suppliers of Raw Materials

Table 70. Cystic Fibrosis Drugs Distributors List

Table 71. Cystic Fibrosis Drugs Customer List

Table 72. Global Cystic Fibrosis Drugs Sales Forecast by Region (2023-2028) & (K Pcs)

Table 73. Global Cystic Fibrosis Drugs Sales Market Forecast by Region

Table 74. Global Cystic Fibrosis Drugs Revenue Forecast by Region (2023-2028) & ($ millions)

Table 75. Global Cystic Fibrosis Drugs Revenue Market Share Forecast by Region (2023-2028)

Table 76. Americas Cystic Fibrosis Drugs Sales Forecast by Country (2023-2028) & (K Pcs)

Table 77. Americas Cystic Fibrosis Drugs Revenue Forecast by Country (2023-2028) & ($ millions)

Table 78. APAC Cystic Fibrosis Drugs Sales Forecast by Region (2023-2028) & (K Pcs)

Table 79. APAC Cystic Fibrosis Drugs Revenue Forecast by Region (2023-2028) & ($ millions)

Table 80. Europe Cystic Fibrosis Drugs Sales Forecast by Country (2023-2028) & (K Pcs)

Table 81. Europe Cystic Fibrosis Drugs Revenue Forecast by Country (2023-2028) & ($ millions)

Table 82. Middle East & Africa Cystic Fibrosis Drugs Sales Forecast by Country (2023-2028) & (K Pcs)

Table 83. Middle East & Africa Cystic Fibrosis Drugs Revenue Forecast by Country (2023-2028) & ($ millions)

Table 84. Global Cystic Fibrosis Drugs Sales Forecast by Type (2023-2028) & (K Pcs)

Table 85. Global Cystic Fibrosis Drugs Sales Market Share Forecast by Type (2023-2028)

Table 86. Global Cystic Fibrosis Drugs Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 87. Global Cystic Fibrosis Drugs Revenue Market Share Forecast by Type (2023-2028)

Table 88. Global Cystic Fibrosis Drugs Sales Forecast by Application (2023-2028) & (K Pcs)

Table 89. Global Cystic Fibrosis Drugs Sales Market Share Forecast by Application (2023-2028)

Table 90. Global Cystic Fibrosis Drugs Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 91. Global Cystic Fibrosis Drugs Revenue Market Share Forecast by Application (2023-2028)

Table 92. Actavis Basic Information, Cystic Fibrosis Drugs Manufacturing Base, Sales Area and Its Competitors

Table 93. Actavis Cystic Fibrosis Drugs Product Offered

Table 94. Actavis Cystic Fibrosis Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 95. Actavis Main Business

Table 96. Actavis Latest Developments

Table 97. F. Hoffmann-La Roche Basic Information, Cystic Fibrosis Drugs Manufacturing Base, Sales Area and Its Competitors

Table 98. F. Hoffmann-La Roche Cystic Fibrosis Drugs Product Offered

Table 99. F. Hoffmann-La Roche Cystic Fibrosis Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 100. F. Hoffmann-La Roche Main Business

Table 101. F. Hoffmann-La Roche Latest Developments

Table 102. Gilead Sciences Basic Information, Cystic Fibrosis Drugs Manufacturing Base, Sales Area and Its Competitors

Table 103. Gilead Sciences Cystic Fibrosis Drugs Product Offered

Table 104. Gilead Sciences Cystic Fibrosis Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 105. Gilead Sciences Main Business

Table 106. Gilead Sciences Latest Developments

Table 107. Novartis Basic Information, Cystic Fibrosis Drugs Manufacturing Base, Sales Area and Its Competitors

Table 108. Novartis Cystic Fibrosis Drugs Product Offered

Table 109. Novartis Cystic Fibrosis Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 110. Novartis Main Business

Table 111. Novartis Latest Developments

Table 112. Vertex Pharmaceuticals Basic Information, Cystic Fibrosis Drugs Manufacturing Base, Sales Area and Its Competitors

Table 113. Vertex Pharmaceuticals Cystic Fibrosis Drugs Product Offered

Table 114. Vertex Pharmaceuticals Cystic Fibrosis Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 115. Vertex Pharmaceuticals Main Business

Table 116. Vertex Pharmaceuticals Latest Developments

Table 117. Abbott Basic Information, Cystic Fibrosis Drugs Manufacturing Base, Sales Area and Its Competitors

Table 118. Abbott Cystic Fibrosis Drugs Product Offered

Table 119. Abbott Cystic Fibrosis Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 120. Abbott Main Business

Table 121. Abbott Latest Developments

Table 122. Anthera Pharmaceuticals Basic Information, Cystic Fibrosis Drugs Manufacturing Base, Sales Area and Its Competitors

Table 123. Anthera Pharmaceuticals Cystic Fibrosis Drugs Product Offered

Table 124. Anthera Pharmaceuticals Cystic Fibrosis Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 125. Anthera Pharmaceuticals Main Business

Table 126. Anthera Pharmaceuticals Latest Developments

Table 127. Arcturus Therapeutics Basic Information, Cystic Fibrosis Drugs Manufacturing Base, Sales Area and Its Competitors

Table 128. Arcturus Therapeutics Cystic Fibrosis Drugs Product Offered

Table 129. Arcturus Therapeutics Cystic Fibrosis Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 130. Arcturus Therapeutics Main Business

Table 131. Arcturus Therapeutics Latest Developments

Table 132. Boehringer Ingelheim Basic Information, Cystic Fibrosis Drugs Manufacturing Base, Sales Area and Its Competitors

Table 133. Boehringer Ingelheim Cystic Fibrosis Drugs Product Offered

Table 134. Boehringer Ingelheim Cystic Fibrosis Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 135. Boehringer Ingelheim Main Business

Table 136. Boehringer Ingelheim Latest Developments

Table 137. Chiesi Farmaceutici Basic Information, Cystic Fibrosis Drugs Manufacturing Base, Sales Area and Its Competitors

Table 138. Chiesi Farmaceutici Cystic Fibrosis Drugs Product Offered

Table 139. Chiesi Farmaceutici Cystic Fibrosis Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 140. Chiesi Farmaceutici Main Business

Table 141. Chiesi Farmaceutici Latest Developments

Table 142. Corbus Pharmaceuticals Basic Information, Cystic Fibrosis Drugs Manufacturing Base, Sales Area and Its Competitors

Table 143. Corbus Pharmaceuticals Cystic Fibrosis Drugs Product Offered

Table 144. Corbus Pharmaceuticals Cystic Fibrosis Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 145. Corbus Pharmaceuticals Main Business

Table 146. Corbus Pharmaceuticals Latest Developments

Table 147. Genzyme Basic Information, Cystic Fibrosis Drugs Manufacturing Base, Sales Area and Its Competitors

Table 148. Genzyme Cystic Fibrosis Drugs Product Offered

Table 149. Genzyme Cystic Fibrosis Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 150. Genzyme Main Business

Table 151. Genzyme Latest Developments

Table 152. Insmed Basic Information, Cystic Fibrosis Drugs Manufacturing Base, Sales Area and Its Competitors

Table 153. Insmed Cystic Fibrosis Drugs Product Offered

Table 154. Insmed Cystic Fibrosis Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 155. Insmed Main Business

Table 156. Insmed Latest Developments

Table 157. Johnson & Johnson Basic Information, Cystic Fibrosis Drugs Manufacturing Base, Sales Area and Its Competitors

Table 158. Johnson & Johnson Cystic Fibrosis Drugs Product Offered

Table 159. Johnson & Johnson Cystic Fibrosis Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 160. Johnson & Johnson Main Business

Table 161. Johnson & Johnson Latest Developments

Table 162. Merck Sharp & Dohme Basic Information, Cystic Fibrosis Drugs Manufacturing Base, Sales Area and Its Competitors

Table 163. Merck Sharp & Dohme Cystic Fibrosis Drugs Product Offered

Table 164. Merck Sharp & Dohme Cystic Fibrosis Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 165. Merck Sharp & Dohme Main Business

Table 166. Merck Sharp & Dohme Latest Developments

Table 167. Neovii Biotech Basic Information, Cystic Fibrosis Drugs Manufacturing Base, Sales Area and Its Competitors

Table 168. Neovii Biotech Cystic Fibrosis Drugs Product Offered

Table 169. Neovii Biotech Cystic Fibrosis Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 170. Neovii Biotech Main Business

Table 171. Neovii Biotech Latest Developments

Table 172. Novo Nordisk Basic Information, Cystic Fibrosis Drugs Manufacturing Base, Sales Area and Its Competitors

Table 173. Novo Nordisk Cystic Fibrosis Drugs Product Offered

Table 174. Novo Nordisk Cystic Fibrosis Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 175. Novo Nordisk Main Business

Table 176. Novo Nordisk Latest Developments

Table 177. PharmaSwiss Basic Information, Cystic Fibrosis Drugs Manufacturing Base, Sales Area and Its Competitors

Table 178. PharmaSwiss Cystic Fibrosis Drugs Product Offered

Table 179. PharmaSwiss Cystic Fibrosis Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 180. PharmaSwiss Main Business

Table 181. PharmaSwiss Latest Developments

Table 182. Pharmaxis Basic Information, Cystic Fibrosis Drugs Manufacturing Base, Sales Area and Its Competitors

Table 183. Pharmaxis Cystic Fibrosis Drugs Product Offered

Table 184. Pharmaxis Cystic Fibrosis Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 185. Pharmaxis Main Business

Table 186. Pharmaxis Latest Developments

Table 187. Proteostasis Therapeutics Basic Information, Cystic Fibrosis Drugs Manufacturing Base, Sales Area and Its Competitors

Table 188. Proteostasis Therapeutics Cystic Fibrosis Drugs Product Offered

Table 189. Proteostasis Therapeutics Cystic Fibrosis Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 190. Proteostasis Therapeutics Main Business

Table 191. Proteostasis Therapeutics Latest Developments

Table 192. PTC Therapeutics Basic Information, Cystic Fibrosis Drugs Manufacturing Base, Sales Area and Its Competitors

Table 193. PTC Therapeutics Cystic Fibrosis Drugs Product Offered

Table 194. PTC Therapeutics Cystic Fibrosis Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 195. PTC Therapeutics Main Business

Table 196. PTC Therapeutics Latest Developments

Table 197. United Medical Basic Information, Cystic Fibrosis Drugs Manufacturing Base, Sales Area and Its Competitors

Table 198. United Medical Cystic Fibrosis Drugs Product Offered

Table 199. United Medical Cystic Fibrosis Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 200. United Medical Main Business

Table 201. United Medical Latest Developments

Table 202. Venus Remedies Basic Information, Cystic Fibrosis Drugs Manufacturing Base, Sales Area and Its Competitors

Table 203. Venus Remedies Cystic Fibrosis Drugs Product Offered

Table 204. Venus Remedies Cystic Fibrosis Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 205. Venus Remedies Main Business

Table 206. Venus Remedies Latest Developments

List of Figures

Figure 1. Picture of Cystic Fibrosis Drugs

Figure 2. Cystic Fibrosis Drugs Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Cystic Fibrosis Drugs Sales Growth Rate 2017-2028 (K Pcs)

Figure 7. Global Cystic Fibrosis Drugs Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Cystic Fibrosis Drugs Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Oral Cystic Fibrosis Drugs

Figure 10. Product Picture of Injection Cystic Fibrosis Drugs

Figure 11. Global Cystic Fibrosis Drugs Sales Market Share by Type in 2021

Figure 12. Global Cystic Fibrosis Drugs Revenue Market Share by Type (2017-2022)

Figure 13. Cystic Fibrosis Drugs Consumed in Hospitals

Figure 14. Global Cystic Fibrosis Drugs Market: Hospitals (2017-2022) & (K Pcs)

Figure 15. Cystic Fibrosis Drugs Consumed in Clinics

Figure 16. Global Cystic Fibrosis Drugs Market: Clinics (2017-2022) & (K Pcs)

Figure 17. Cystic Fibrosis Drugs Consumed in Other

Figure 18. Global Cystic Fibrosis Drugs Market: Other (2017-2022) & (K Pcs)

Figure 19. Global Cystic Fibrosis Drugs Sales Market Share by Application (2017-2022)

Figure 20. Global Cystic Fibrosis Drugs Revenue Market Share by Application in 2021

Figure 21. Cystic Fibrosis Drugs Revenue Market by Company in 2021 ($ Million)

Figure 22. Global Cystic Fibrosis Drugs Revenue Market Share by Company in 2021

Figure 23. Global Cystic Fibrosis Drugs Sales Market Share by Geographic Region (2017-2022)

Figure 24. Global Cystic Fibrosis Drugs Revenue Market Share by Geographic Region in 2021

Figure 25. Global Cystic Fibrosis Drugs Sales Market Share by Region (2017-2022)

Figure 26. Global Cystic Fibrosis Drugs Revenue Market Share by Country/Region in 2021

Figure 27. Americas Cystic Fibrosis Drugs Sales 2017-2022 (K Pcs)

Figure 28. Americas Cystic Fibrosis Drugs Revenue 2017-2022 ($ Millions)

Figure 29. APAC Cystic Fibrosis Drugs Sales 2017-2022 (K Pcs)

Figure 30. APAC Cystic Fibrosis Drugs Revenue 2017-2022 ($ Millions)

Figure 31. Europe Cystic Fibrosis Drugs Sales 2017-2022 (K Pcs)

Figure 32. Europe Cystic Fibrosis Drugs Revenue 2017-2022 ($ Millions)

Figure 33. Middle East & Africa Cystic Fibrosis Drugs Sales 2017-2022 (K Pcs)

Figure 34. Middle East & Africa Cystic Fibrosis Drugs Revenue 2017-2022 ($ Millions)

Figure 35. Americas Cystic Fibrosis Drugs Sales Market Share by Country in 2021

Figure 36. Americas Cystic Fibrosis Drugs Revenue Market Share by Country in 2021

Figure 37. United States Cystic Fibrosis Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 38. Canada Cystic Fibrosis Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 39. Mexico Cystic Fibrosis Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 40. Brazil Cystic Fibrosis Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 41. APAC Cystic Fibrosis Drugs Sales Market Share by Region in 2021

Figure 42. APAC Cystic Fibrosis Drugs Revenue Market Share by Regions in 2021

Figure 43. China Cystic Fibrosis Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 44. Japan Cystic Fibrosis Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 45. South Korea Cystic Fibrosis Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 46. Southeast Asia Cystic Fibrosis Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 47. India Cystic Fibrosis Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 48. Australia Cystic Fibrosis Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 49. Europe Cystic Fibrosis Drugs Sales Market Share by Country in 2021

Figure 50. Europe Cystic Fibrosis Drugs Revenue Market Share by Country in 2021

Figure 51. Germany Cystic Fibrosis Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 52. France Cystic Fibrosis Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 53. UK Cystic Fibrosis Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 54. Italy Cystic Fibrosis Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 55. Russia Cystic Fibrosis Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 56. Middle East & Africa Cystic Fibrosis Drugs Sales Market Share by Country in 2021

Figure 57. Middle East & Africa Cystic Fibrosis Drugs Revenue Market Share by Country in 2021

Figure 58. Egypt Cystic Fibrosis Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 59. South Africa Cystic Fibrosis Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 60. Israel Cystic Fibrosis Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 61. Turkey Cystic Fibrosis Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 62. GCC Country Cystic Fibrosis Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 63. Manufacturing Cost Structure Analysis of Cystic Fibrosis Drugs in 2021

Figure 64. Manufacturing Process Analysis of Cystic Fibrosis Drugs

Figure 65. Industry Chain Structure of Cystic Fibrosis Drugs

Figure 66. Channels of Distribution

Figure 67. Distributors Profiles

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390